Clinical Trial Update: A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients [Phase 2]

View source ↗

Summary

Phase 2 study assessing RO4607381 on vascular function in patients with Coronary Heart Disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• RO4607381

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Coronary Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-01-02